JP Morgan Chase’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-10,183
| Closed | -$12K | – | 7290 |
|
|
2022
Q3 | $12K | Buy |
10,183
+4,543
| +81% | +$7.08K | ﹤0.01% | 5937 |
|
|
2022
Q2 | $10K | Sell |
5,640
-64,132
| -92% | -$94.6K | ﹤0.01% | 6044 |
|
|
2022
Q1 | $141K | Buy |
69,772
+13,413
| +24% | +$26.3K | ﹤0.01% | 5362 |
|
|
2021
Q4 | $153K | Buy |
56,359
+4,913
| +10% | +$18.2K | ﹤0.01% | 5495 |
|
|
2021
Q3 | $229K | Buy |
51,446
+7,191
| +16% | +$34.6K | ﹤0.01% | 5165 |
|
|
2021
Q2 | $257K | Sell |
44,255
-129,636
| -75% | -$760K | ﹤0.01% | 5099 |
|
|
2021
Q1 | $1.22M | Sell |
173,891
-43,246
| -20% | -$290K | ﹤0.01% | 4085 |
|
|
2020
Q4 | $1.04M | Sell |
217,137
-32,399
| -13% | -$164K | ﹤0.01% | 3936 |
|
|
2020
Q3 | $1.48M | Sell |
249,536
-18,641
| -7% | -$112K | ﹤0.01% | 3427 |
|
|
2020
Q2 | $1.81M | Sell |
268,177
-64,794
| -19% | -$491K | ﹤0.01% | 3171 |
|
|
2020
Q1 | $2.12M | Sell |
332,971
-93,072
| -22% | -$747K | ﹤0.01% | 2928 |
|
|
2019
Q4 | $4.44M | Buy |
426,043
+193,400
| +83% | +$1.41M | ﹤0.01% | 2777 |
|
|
2019
Q3 | $915K | Sell |
232,643
-107,244
| -32% | -$868K | ﹤0.01% | 3887 |
|
|
2019
Q2 | $4.59M | Buy |
339,887
+132,183
| +64% | +$2.39M | ﹤0.01% | 2710 |
|
|
2019
Q1 | $5.16M | Buy |
207,704
+50,762
| +32% | +$1.27M | ﹤0.01% | 2558 |
|
|
2018
Q4 | $2.82M | Sell |
156,942
-319,549
| -67% | -$6.53M | ﹤0.01% | 3029 |
|
|
2018
Q3 | $14M | Buy |
476,491
+233,003
| +96% | +$9.02M | ﹤0.01% | 1924 |
|
|
2018
Q2 | $11.1M | Buy |
243,488
+25,407
| +12% | +$1.24M | ﹤0.01% | 2054 |
|
|
2018
Q1 | $11.5M | Buy |
218,081
+50,664
| +30% | +$2.96M | ﹤0.01% | 1923 |
|
|
2017
Q4 | $11.4M | Buy |
167,417
+98,271
| +142% | +$6.87M | ﹤0.01% | 2020 |
|
|
2017
Q3 | $5.54M | Buy |
69,146
+25,931
| +60% | +$2.06M | ﹤0.01% | 2494 |
|
|
2017
Q2 | $4.05M | Sell |
43,215
-119,526
| -73% | -$7.31M | ﹤0.01% | 2613 |
|
|
2017
Q1 | $10.4M | Sell |
162,741
-7,647
| -4% | -$465K | ﹤0.01% | 1912 |
|
|
2016
Q4 | $7.57M | Sell |
170,388
-7,749
| -4% | -$273K | ﹤0.01% | 2127 |
|
|
2016
Q3 | $6.42M | Buy |
178,137
+98,838
| +125% | +$2.12M | ﹤0.01% | 2071 |
|
|
2016
Q2 | $1.09M | Sell |
79,299
-137,286
| -63% | -$2.01M | ﹤0.01% | 3136 |
|
|
2016
Q1 | $4.16M | Buy |
216,585
+37,243
| +21% | +$788K | ﹤0.01% | 2315 |
|
|
2015
Q4 | $6.28M | Buy |
179,342
+21,078
| +13% | +$1.36M | ﹤0.01% | 2084 |
|
|
2015
Q3 | $14.6M | Sell |
158,264
-39,036
| -20% | -$3.38M | ﹤0.01% | 1483 |
|
|
2015
Q2 | $17.3M | Buy |
197,300
+4,235
| +2% | +$363K | ﹤0.01% | 1500 |
|
|
2015
Q1 | $14.3M | Buy |
193,065
+20,443
| +12% | +$1.44M | ﹤0.01% | 1657 |
|
|
2014
Q4 | $9.67M | Buy |
172,622
+151,744
| +727% | +$7.98M | ﹤0.01% | 1977 |
|
|
2014
Q3 | $947K | Sell |
20,878
-8,909
| -30% | -$372K | ﹤0.01% | 3368 |
|
|
2014
Q2 | $1.24M | Sell |
29,787
-78,952
| -73% | -$4.07M | ﹤0.01% | 2762 |
|
|
2014
Q1 | $7.53M | Buy |
108,739
+40,713
| +60% | +$2.99M | ﹤0.01% | 1870 |
|
|
2013
Q4 | $4.1M | Sell |
68,026
-10,908
| -14% | -$593K | ﹤0.01% | 2299 |
|
|
2013
Q3 | $4.8M | Sell |
78,934
-39,599
| -33% | -$2.81M | ﹤0.01% | 2209 |
|
|
2013
Q2 | $7.94M | Buy |
+118,533
| New | +$5.33M | ﹤0.01% | 1825 |
|
Other funds holding CLVS
IA
CAS
CASC
STB
MCM
WS
FFWM
NFSG